NUTRA PHARMA CORP. Proceeds from Sale of Notes Receivable
NUTRA PHARMA CORP. (NPHC) reported Proceeds from Sale of Notes Receivable of $42.30 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-05-20.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfNotesReceivable · last filed 2026-05-20
- NUTRA PHARMA CORP. proceeds from sale of notes receivable for the quarter ending 2024-12-31 was $8.30K.
- NUTRA PHARMA CORP. proceeds from sale of notes receivable for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- NUTRA PHARMA CORP. proceeds from sale of notes receivable for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- NUTRA PHARMA CORP. proceeds from sale of notes receivable for the quarter ending 2023-06-30 was $2.50K.
- NUTRA PHARMA CORP. proceeds from sale of notes receivable for fiscal 2024 was $42.30K, a 238.40% increase from fiscal 2023.
- NUTRA PHARMA CORP. proceeds from sale of notes receivable for fiscal 2023 was $12.50K, a 87.71% decline from fiscal 2022.
- NUTRA PHARMA CORP. proceeds from sale of notes receivable for fiscal 2022 was $101.75K.
| Period end | Proceeds from Sale of Notes Receivable 3 month | Proceeds from Sale of Notes Receivable 3 month as first filed | Proceeds from Sale of Notes Receivable 6 month | Proceeds from Sale of Notes Receivable 9 month | Proceeds from Sale of Notes Receivable 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $8.30K derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $42.30K 10-K · filed 2026-05-20 | |||
| 2024-09-30 | $34.00K 10-Q · filed 2026-04-06 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $0.00 derived: sum of 2 quarters · filed 2026-02-17 | $2.50K derived: sum of 3 quarters · filed 2026-02-17 | $12.50K 10-K · filed 2026-02-17 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-01-02 | $2.50K derived: sum of 2 quarters · filed 2026-01-02 | $12.50K 10-Q · filed 2026-01-02 | $114.25K derived: sum of 4 quarters · filed 2026-01-02 | |
| 2023-06-30 | $2.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-23 | $12.50K 10-Q · filed 2025-12-23 | $114.25K derived: sum of 3 quarters · filed 2025-12-23 | $216.00K derived: sum of 4 quarters · filed 2025-12-23 | |
| 2023-03-31 | $10.00K 10-Q · filed 2025-12-17 | $111.75K derived: sum of 2 quarters · filed 2025-12-17 | $213.50K derived: sum of 3 quarters · filed 2025-12-17 | ||
| 2022-12-31 | $101.75K 10-K · filed 2025-11-24 | $203.50K derived: sum of 2 quarters · filed 2025-11-24 | $101.75K 10-K · filed 2025-11-24 | ||
| 2022-09-30 | $101.75K 10-K · filed 2025-11-24 | $50.25K 10-Q · filed 2022-11-21 | $50.25K 10-Q · filed 2025-10-28 |